IL114989A - History of Campaignin with an open E-ring Preparation and anti-tumor drugs containing them - Google Patents

History of Campaignin with an open E-ring Preparation and anti-tumor drugs containing them

Info

Publication number
IL114989A
IL114989A IL11498995A IL11498995A IL114989A IL 114989 A IL114989 A IL 114989A IL 11498995 A IL11498995 A IL 11498995A IL 11498995 A IL11498995 A IL 11498995A IL 114989 A IL114989 A IL 114989A
Authority
IL
Israel
Prior art keywords
hexane
nmr
chloroform
hydrogen
group
Prior art date
Application number
IL11498995A
Other languages
English (en)
Hebrew (he)
Other versions
IL114989A0 (en
Original Assignee
Yakult Honsha Kk
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yakult Honsha Kk, Daiichi Seiyaku Co filed Critical Yakult Honsha Kk
Publication of IL114989A0 publication Critical patent/IL114989A0/xx
Publication of IL114989A publication Critical patent/IL114989A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
IL11498995A 1994-09-06 1995-08-17 History of Campaignin with an open E-ring Preparation and anti-tumor drugs containing them IL114989A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6246660A JPH0873461A (ja) 1994-09-06 1994-09-06 新規なカンプトテシン誘導体、その製造法および抗腫瘍剤

Publications (2)

Publication Number Publication Date
IL114989A0 IL114989A0 (en) 1995-12-08
IL114989A true IL114989A (en) 1998-09-24

Family

ID=17151729

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11498995A IL114989A (en) 1994-09-06 1995-08-17 History of Campaignin with an open E-ring Preparation and anti-tumor drugs containing them

Country Status (17)

Country Link
US (1) US5843954A (de)
EP (1) EP0700914B1 (de)
JP (1) JPH0873461A (de)
KR (1) KR100351952B1 (de)
CN (1) CN1052482C (de)
AT (1) ATE192447T1 (de)
AU (1) AU688547B2 (de)
CA (1) CA2157128C (de)
DE (1) DE69516605T2 (de)
DK (1) DK0700914T3 (de)
ES (1) ES2146275T3 (de)
GR (1) GR3033798T3 (de)
IL (1) IL114989A (de)
NZ (1) NZ272904A (de)
PT (1) PT700914E (de)
RU (1) RU2133748C1 (de)
ZA (1) ZA957269B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4094710B2 (ja) 1997-11-06 2008-06-04 株式会社ヤクルト本社 新規なカンプトテシン誘導体
FR2792937B1 (fr) 1999-04-27 2001-08-10 Cemaf NOUVEAUX DERIVES DE PYRROLO-(3,4-b) QUINOLEINE, LEUR PROCEDE DE PREPARATION ET LEUR UTILISATION A TITRE DE MEDICAMENT
CA2385528C (en) 1999-10-01 2013-12-10 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
AR027687A1 (es) 2000-03-22 2003-04-09 Yakult Honsha Kk Procedimiento para preparar camptotecina
CZ299329B6 (cs) * 2003-08-26 2008-06-18 Pliva-Lachema A.S. Zpusob výroby 7-ethyl-10-[ 4-(1-piperidino)-1-piperidino]karbonyloxykamptothecinu
CZ299593B6 (cs) * 2003-12-16 2008-09-10 Pliva-Lachema A. S. Zpusob výroby 7-ethyl-10-hydroxykamptothecinu
ITMI20051348A1 (it) * 2005-07-14 2007-01-15 Indena Spa Analoghi della camptotecina loro processo di ottenimento loro uso e formulazioni che li contengono
CN100339377C (zh) * 2005-09-05 2007-09-26 合肥中科大生物技术有限公司 喜树碱衍生物及其制备
CN1319971C (zh) * 2005-09-09 2007-06-06 合肥中科大生物技术有限公司 喜树碱衍生物及其用途
CN102746314B (zh) * 2011-04-18 2016-07-06 华东师范大学 含有稳定7元内酯环的喜树碱类化合物、制备方法和用途
US11814394B2 (en) 2021-11-16 2023-11-14 Genequantum Healthcare (Suzhou) Co., Ltd. Exatecan derivatives, linker-payloads, and conjugates and thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5839684A (ja) * 1981-09-04 1983-03-08 Yakult Honsha Co Ltd 10−置換カンプテシン誘導体の製造法
JPS5951287A (ja) * 1982-09-17 1984-03-24 Yakult Honsha Co Ltd 新規なカンプトテシン誘導体
US4981968A (en) * 1987-03-31 1991-01-01 Research Triangle Institute Synthesis of camptothecin and analogs thereof
US5049668A (en) * 1989-09-15 1991-09-17 Research Triangle Institute 10,11-methylenedioxy-20(RS)-camptothecin analogs
US5122606A (en) * 1987-04-14 1992-06-16 Research Triangle Institute 10,11-methylenedioxy camptothecins
JP2540357B2 (ja) * 1987-06-24 1996-10-02 第一製薬株式会社 六環性化合物
JP2538792B2 (ja) 1987-06-25 1996-10-02 株式会社ヤクルト本社 新規なカンプトテシン誘導体
CA1332413C (en) * 1987-06-25 1994-10-11 Kabushiki Kaisha Yakult Honsha Camptothecin derivatives and process for preparing same
JPH0615547B2 (ja) * 1988-01-20 1994-03-02 株式会社ヤクルト本社 新規なカンプトテシン誘導体
WO1991004260A2 (en) * 1989-09-15 1991-04-04 Research Triangle Institute 10,11-methylenedioxy-20(rs)-camptothecin and 10,11-methylenedioxy-20(s)-camptothecin analogs
US5162532A (en) * 1990-12-20 1992-11-10 North Carolina State University Intermediates and method of making camptothecin and camptothecin analogs

Also Published As

Publication number Publication date
CA2157128C (en) 2006-04-11
CA2157128A1 (en) 1996-03-07
CN1126212A (zh) 1996-07-10
IL114989A0 (en) 1995-12-08
AU688547B2 (en) 1998-03-12
KR960010644A (ko) 1996-04-20
EP0700914B1 (de) 2000-05-03
CN1052482C (zh) 2000-05-17
JPH0873461A (ja) 1996-03-19
NZ272904A (en) 1996-08-27
ES2146275T3 (es) 2000-08-01
EP0700914A1 (de) 1996-03-13
US5843954A (en) 1998-12-01
ATE192447T1 (de) 2000-05-15
PT700914E (pt) 2000-09-29
DK0700914T3 (da) 2000-07-31
AU3047495A (en) 1996-03-21
GR3033798T3 (en) 2000-10-31
ZA957269B (en) 1996-03-25
RU2133748C1 (ru) 1999-07-27
DE69516605D1 (de) 2000-06-08
KR100351952B1 (ko) 2002-12-28
DE69516605T2 (de) 2000-10-26

Similar Documents

Publication Publication Date Title
JP6267397B1 (ja) 置換された多環性ピリドン誘導体およびそのプロドラッグを含有する医薬組成物
CN102933572B (zh) 吡唑-4-基-杂环基-甲酰胺化合物及其使用方法
ES2248531T3 (es) Derivados de lactamas y sultamas y su uso como inhibidores de histona desacetilasa.
TW202309042A (zh) 依沙替康(exatecan)衍生物及其抗體藥物結合物
CN111094288B (zh) 具有mgat-2抑制活性的稠合环衍生物
TW201124378A (en) Indole compounds and pharmaceutical use thereof
EP4257137A2 (de) Polycyclische carbamoylpyridonderivate zur behandlung von hiv
IL114989A (en) History of Campaignin with an open E-ring Preparation and anti-tumor drugs containing them
CN115151541A (zh) 新型化合物及其用途
WO2023056936A1 (zh) 一种核苷酸衍生物及其药物组合物和用途
CN112047944A (zh) 一种选择性抑制激酶化合物及其用途
CA3196061A1 (en) Cftr modulator compounds, compositions, and uses thereof
CN105399698A (zh) 芳杂环类衍生物及其在药物中的应用
KR19980703022A (ko) 3-(비스-치환 페닐메틸렌)옥신돌 유도체
JPS63152374A (ja) ヒドロキシブテノライド誘導体およびその製造法
CA3233328A1 (en) Lpxc inhibitors and uses thereof
CN117242061A (zh) 用于治疗艰难梭菌的二氮杂卓衍生物
BR112021012428A2 (pt) Derivado de dihidropirazolopirazinona tendo atividade inibitória de mgat2
BG108347A (bg) Нови производни на 5-тио-бета-d-ксилопиранозиди, метод за получаване, фармацевтични състави които ги съдържат и тяхното използване за терапия
KR101032006B1 (ko) 히드록시모르폴리논 유도체 및 이의 의약 용도
WO2023233994A1 (ja) 医薬組成物及びオートファジー活性化剤
JP7201181B2 (ja) ペプチド系抗腫瘍薬の創製
KR101881115B1 (ko) 신규 2-치환된 테트라하이드로피란 또는 2-치환된 테트라하이드로퓨란 유도체 화합물, 이의 제조방법 및 이의 용도
TW202339735A (zh) 氘化rock抑制劑、醫藥組合物及治療應用
JP2007503376A (ja) 新規n−置換インドリル−3−グリオキシル酸アミド、医薬品としてのその使用及びその製造方法

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees